Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1578 USD | -28.97% | -34.00% | -19.08% |
May. 30 | Transcript : CytoDyn Inc. - Special Call | |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -28.97% | ||
1 week | -34.00% | ||
1 month | +16.37% | ||
3 months | -22.07% | ||
6 months | -24.86% | ||
Current year | -19.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.1578 | -29.82% | 19,513,858 |
24-05-30 | 0.2248 | -7.58% | 5,893,143 |
24-05-29 | 0.2432 | -18.90% | 7,028,793 |
24-05-28 | 0.2999 | +25.44% | 8,680,330 |
24-05-24 | 0.2391 | +1.10% | 771,065 |
Delayed Quote OTC Markets, May 31, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.08% | 157M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CYDY Stock